Bryce D. Carmine
2010
In 2010, Bryce D. Carmine earned a total compensation of $7.7M as Retired Executive Vice President and President, Lilly Bio-Medicines at Lilly Eli & Co, a 11% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,252,560 |
|---|---|
| Non-Equity Incentive Plan | $1,210,373 |
| Salary | $947,083 |
| Stock Awards | $3,270,000 |
| Other | $56,825 |
| Total | $7,736,841 |
Carmine received $3.3M in stock awards, accounting for 42% of the total pay in 2010.
Carmine also received $2.3M of change in pension value and nonqualified deferred compensation earnings, $1.2M in non-equity incentive plan, $947.1K in salary and $56.8K in other compensation.
Rankings
In 2010, Bryce D. Carmine's compensation ranked 540th out of 10,439 executives tracked by ExecPay. In other words, Carmine earned more than 94.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 540 out of 10,439 | 95th |
Division Manufacturing | 183 out of 3,837 | 95th |
Major group Chemicals And Allied Products | 40 out of 925 | 96th |
Industry group Drugs | 23 out of 684 | 97th |
Industry Pharmaceutical Preparations | 19 out of 480 | 96th |
Source: SEC filing on March 5, 2012.
Carmine's colleagues
We found five more compensation records of executives who worked with Bryce D. Carmine at Lilly Eli & Co in 2010.
2010
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
2010
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology and President, Lilly Research Laboratories
2010
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2010
Robert Armitage
Lilly Eli & Co
General Counsel
2010
Enrique Conterno
Lilly Eli & Co